XTL Biopharmaceuticals Ltd. (XTLB)

XTL Biopharmaceuticals Statistics

Total Valuation

XTLB has a market cap or net worth of $17.54 million. The enterprise value is $15.17 million.

Market Cap	17.54M
Enterprise Value	15.17M

Important Dates

The next estimated earnings date is Thursday, February 20, 2025, before market open.

Earnings Date	Feb 20, 2025
Ex-Dividend Date	n/a

Share Statistics

XTLB has 544.91 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	544.91M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.12B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	7.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.43

Current Ratio	11.43
Quick Ratio	10.49
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -13.07% and return on invested capital (ROIC) is -14.89%.

Return on Equity (ROE)	-13.07%
Return on Assets (ROA)	-13.78%
Return on Capital (ROIC)	-14.89%
Revenue Per Employee	n/a
Profits Per Employee	-$54,000
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +46.97% in the last 52 weeks. The beta is 1.00, so XTLB's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	+46.97%
50-Day Moving Average	1.84
200-Day Moving Average	2.32
Relative Strength Index (RSI)	30.63
Average Volume (20 Days)	12,827

Short Selling Information

Short Interest	74,955
Short Previous Month	75,243
Short % of Shares Out	1.02%
Short % of Float	n/a
Short Ratio (days to cover)	3.35

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-689,000
Pretax Income	-1.78M
Net Income	-378,000
EBITDA	n/a
EBIT	-689,000
Earnings Per Share (EPS)	-$0.00

Balance Sheet

Cash & Cash Equivalents	2.34M
Total Debt	n/a
Net Cash	2.34M
Net Cash Per Share	$0.00
Equity (Book Value)	2.71M
Book Value Per Share	0.00
Working Capital	2.33M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XTLB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.16%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on February 10, 2017. It was a reverse split with a ratio of 0.2:1.

Last Split Date	Feb 10, 2017
Split Type	Reverse
Split Ratio	0.2:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a